Stay updated on Navarixin and Pembrolizumab Combination Clinical Trial
Sign up to get notified when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.

Latest updates to the Navarixin and Pembrolizumab Combination Clinical Trial page
- Check3 days agoChange DetectedRevision notes show v3.3.4 added and v3.3.3 removed, indicating a minor behind-the-scenes update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new Locations section lists additional study sites in the United States, Australia, Canada, and Israel, expanding where the trial is available. The HHS Vulnerability Disclosure link and several location-specific pages were removed as part of a site cleanup.SummaryDifference1%

- Check47 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1; no other changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedThe Publications note text was updated to clarify that publications are provided voluntarily and relate to the study results; the revision tag was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedA time-sensitive government funding notice was removed from the page, with no change to core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check75 days agoChange DetectedPublications section updated with a 2024 article citation for this trial, indicating disseminated results.SummaryDifference0.4%

Stay in the know with updates to Navarixin and Pembrolizumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.